Hoechst Pharmaceuticals Ltd. v. State of Bihar (1983)

The case of Hoechst Pharmaceuticals Ltd. & Ors. v. State of Bihar & Ors. (1983) is a landmark judgement of the Supreme Court of India that clarified the scope of legislative competence under Article 246 of the Constitution, the doctrine of repugnancy under Article 254, and the independence of state taxing powers under the Seventh Schedule.

At the heart of the case was the conflict between the Bihar Finance Act, 1981 and the Drugs (Price Control) Order, 1979 (DPCO). Pharmaceutical companies argued that the surcharge imposed by the State was unconstitutional as drug prices were already controlled by the Central Government. The Supreme Court, however, upheld the validity of the State law and provided clarity on the constitutional scheme of taxation.

Details of Hoechst Pharmaceuticals Ltd. v. State of Bihar Case

• Court: Supreme Court of India
• Citation: (1983) 4 SCC 45
• Bench: A.P. Sen, E.S. Venkataramiah, R.B. Misra
• Date of Decision: 6 May 1983
• Appellants: Hoechst Pharmaceuticals Ltd. & Others
• Respondents: State of Bihar & Others
• Relevant Laws:
  
  • Articles 14, 19(1)(g), 246 and 254 of the Constitution of India
  • Section 5(1) and 5(3), Bihar Finance Act, 1981
  • Paragraph 21, Drugs (Price Control) Order, 1979

Background of Hoechst Pharmaceuticals Ltd. v. State of Bihar

The State of Bihar enacted the Bihar Finance Act, 1981 to impose a surcharge on dealers.

• Section 5(1): Levied a surcharge on every dealer whose annual gross turnover exceeded ₹5 lakhs. The surcharge could not exceed 10% of the total tax payable.
• Section 5(3): Prohibited dealers from collecting the surcharge amount from consumers.

At the same time, the Drugs (Price Control) Order, 1979, issued by the Central Government under Section 3 of the Essential Commodities Act, 1955, fixed controlled prices for drugs and formulations. This allowed manufacturers to pass on sales tax to consumers within the controlled price.

Pharmaceutical companies, including Hoechst Pharmaceuticals Ltd. and Glaxo Laboratories, challenged the surcharge provisions, arguing that they conflicted with the DPCO and violated their fundamental rights.

Facts of Hoechst Pharmaceuticals Ltd. v. State of Bihar Case

1. The appellants were engaged in the manufacture and distribution of pharmaceuticals in India, including in Bihar.
2. They maintained wholesale outlets in Bihar and sold drugs to retailers.
3. Nearly 94% of their products were sold at controlled prices under the DPCO.
4. Under the DPCO, prices were fixed by the Central Government and included local taxes such as sales tax and octroi.
5. The Bihar Finance Act, 1981 introduced a surcharge on dealers with turnover above ₹5 lakhs. Dealers were prohibited from passing this surcharge to consumers.
6. The appellants argued that this prohibition conflicted with Paragraph 21 of the DPCO, which allowed sales tax to be included in the controlled price.
7. They also contended that the surcharge violated Articles 14 and 19(1)(g) of the Constitution.

Issues Raised

1. Whether Sections 5(1) and 5(3) of the Bihar Finance Act, 1981 were inconsistent with Paragraph 21 of the Drugs (Price Control) Order, 1979, and therefore void under Article 254?
2. Whether the provisions violated the appellants’ fundamental rights under Articles 14 and 19(1)(g)?
3. Whether the State Legislature had the competence under Article 246 to enact the surcharge provisions?

Arguments of the Appellants

The appellants (pharmaceutical companies) raised the following key points:

• Conflict with Central Law: The DPCO permitted manufacturers to include sales tax in controlled prices, while the Bihar Act prohibited passing the surcharge to consumers. This created a direct conflict between the two laws.
• Violation of Fundamental Rights: The surcharge was confiscatory and imposed an unreasonable burden on drug manufacturers. It violated Article 19(1)(g) (right to trade and business). By treating controlled commodities dealers at par with others, it created unreasonable classification, violating Article 14.
• Beyond State’s Power: The turnover considered under Section 5(1) included inter-State, import, and export sales, which fell outside State competence under Article 286. The State Legislature’s power was subordinate to the Union’s power over essential commodities (Entry 33, List III).
• Doctrine of Occupied Field: By enacting DPCO, the Union had already occupied the field of drug pricing, leaving no room for State legislation.

Arguments of the Respondents

The State of Bihar defended the Act as follows:

• No Repugnancy: Repugnancy under Article 254 arises only when both Union and State legislate on a subject in the Concurrent List. The surcharge was under Entry 54, List II (State List: taxes on sale/purchase of goods), while DPCO was under Entry 33, List III (Concurrent List: trade and commerce in essential commodities). Thus, the two operated in distinct fields.
• Pith and Substance Doctrine: In substance, the Bihar Act was a taxing law, not a price control law. Its validity had to be judged based on its true nature, not incidental overlaps. 
• Maximum Price Concept: DPCO fixed maximum prices; manufacturers were free to sell below them. The surcharge could be absorbed within these margins and did not conflict with DPCO.
• No Violation of Rights: Levying a surcharge was a legitimate taxing power. The dealers had not proved that it was confiscatory or destroyed their business.

Relevant Constitutional Provisions

1. Article 14 – Equality before the law.
2. Article 19(1)(g) – Right to practice any profession or carry on trade or business.
3. Article 246 – Distribution of legislative powers between Union and States.
   • Clause (1): Union List powers.
   • Clause (2): Concurrent List powers.
   • Clause (3): State List powers.
4. Article 254 – Doctrine of repugnancy (conflict between State and Union laws).

Judgements Referred in Hoechst Pharmaceuticals Ltd. v. State of Bihar

• Province of Madras v. Boddu Paidanna (1941) – Legislative entries should be interpreted using pith and substance.
• S. Kodar v. State of Kerala (1974) – Upheld additional sales tax; confirmed State’s power to impose surcharges.
• Shree Meenakshi Mills Ltd. v. Union of India (1974) – Price controls ensure consumer interest; not unconstitutional.
• Prag Ice & Oil Mills v. Union of India (1978) – Economic laws are valid unless clearly arbitrary or discriminatory. 

Judgement of the Supreme Court in Hoechst Pharmaceuticals Ltd. v. State of Bihar

The Supreme Court dismissed the appeals and upheld the Patna High Court’s judgement.

Key Findings:

1. Legislative Competence: Section 5(1) surcharge is in the nature of a sales tax. Falls within Entry 54, List II – validly enacted by State Legislature. State has power to decide incidence of tax, including whether dealers can pass it to consumers.
2. No Repugnancy: The Bihar Finance Act (tax law) and DPCO (price control law) operate in separate fields. For repugnancy, both laws must be under Concurrent List – not the case here.
3. No Violation of Fundamental Rights: The surcharge was not confiscatory. Article 14 not violated as levy applied uniformly to dealers with turnover above ₹5 lakhs. Article 19(1)(g) not violated as tax imposition is a legitimate legislative act.
4. Judicial Review Limited: The Court cannot interfere with economic wisdom of taxation. Determination of tax policy lies exclusively with the legislature.

Conclusion

The judgement in Hoechst Pharmaceuticals Ltd. v. State of Bihar (1983) upheld the legislative competence of the Bihar Finance Act, 1981, and confirmed that there was no conflict with the Drugs (Price Control) Order, 1979. It reinforced the principle that State taxing powers are independent and distinct from Union regulatory powers, provided they operate within their respective fields.